Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

APOE*4 risk-modifying genes and drug targets in Alzheimer's disease through cell-type-specific genomic analyses.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Genetic Investigation of Corrected QT Interval Sensitivity to Oral Bepridil Hydrochloride Hydrate in Patients With Atrial Fibrillation.

Journal of the American Heart Association·2026
Same author

Machine Learning Reveals the Contribution of Rare Genetic Variants and Enhances Risk Prediction for Coronary Artery Disease in the Japanese Population.

Circulation. Genomic and precision medicine·2026
Same author

Genetic Variants Associated With Nonpulmonary Vein Triggers of Atrial Fibrillation: A Genome-Wide Association Study.

JACC. Advances·2026
Same author

Reply to "Letter to "Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis"".

Journal of gastroenterology·2026
Same author

Whole-genome sequencing reveals an East Asian-specific rare variant of INPP5J associated with Alzheimer's disease.

Translational psychiatry·2026

Related Experiment Video

Updated: Oct 15, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K

Dementia subtype prediction models constructed by penalized regression methods for multiclass classification using

Yuya Asanomi1, Daichi Shigemizu2,3,4, Shintaro Akiyama1

  • 1Medical Genome Center, Research Institute, National Center for Geriatrics and Gerontology, 7-430 Morioka-cho, Obu, Aichi, 474-8511, Japan.

Scientific Reports
|October 23, 2021
PubMed
Summary

Researchers identified 46 blood microRNAs (miRNAs) that can accurately predict dementia subtypes, including Alzheimer's disease. This discovery offers potential for non-invasive, low-cost diagnostic tools for various dementia types.

More Related Videos

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
09:26

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR

Published on: January 22, 2014

15.6K

Related Experiment Videos

Last Updated: Oct 15, 2025

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.8K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR
09:26

Cerebrospinal Fluid MicroRNA Profiling Using Quantitative Real Time PCR

Published on: January 22, 2014

15.6K

Area of Science:

  • Biomarkers
  • Neuroscience
  • Genomics

Background:

  • Dementia diagnosis requires minimally-invasive, cost-effective biomarkers.
  • Circulating microRNAs (miRNAs) show promise as accessible, non-invasive biomarkers.

Purpose of the Study:

  • To develop and validate a predictive model for dementia subtypes using serum miRNA expression.
  • To identify novel diagnostic biomarkers for Alzheimer's disease (AD), vascular dementia, dementia with Lewy bodies (DLB), and normal pressure hydrocephalus.

Main Methods:

  • Comprehensive miRNA expression analysis of serum samples from 1348 dementia patients and 246 controls.
  • Construction of dementia subtype prediction models using penalized regression and multiclass classification.
  • Network analysis of miRNA target genes to identify key pathogenic genes.

Main Results:

  • A final prediction model using 46 miRNAs accurately classified dementia subtypes in an independent validation set.
  • Hub genes SRC and CHD3 were identified as associated with AD pathogenesis.
  • Genes MCU and CASP3, linked to DLB pathogenesis, were identified from DLB-specific target genes.

Conclusions:

  • Blood-based miRNA expression profiles can serve as effective biomarkers for dementia subtype prediction.
  • This study highlights the potential for developing accurate, non-invasive diagnostic tools for dementia.
  • Further validation with larger sample sizes is recommended for enhanced classification accuracy.